It is a chemicals and materials private limited company based in Aurangabad, Maharashtra, India, established in 2019.
2019 | Aurangabad, Maharashtra, India | ActiveDelmax Pharmaceuticals Private Limited, a active private limited company, was established on 17 June 2019 in Aurangabad, Maharashtra, India. Engaging in chemical distribution & retail within the manufacturing sector, it holds CIN: U24100MH2019PTC326834. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Dattatray Janardhan Pannabhatti (Director), Bhagyashri Sachin Daskhedkar (Director). Past directors included Renuka Vijay Giri, Bhagyashri Sachin Daskhedkar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No As-05, Udyog, Indrakamal A Type, Gut No. 70, Beed By Pass Road, Aurangabad, Maharashtra, 431001.
U24100MH2019PTC326834
326834
17 June 2019
₹0.50 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Delmax Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dattatray Janardhan Pannabhatti | Director | 17 Jun 2019 | Current |
| Bhagyashri Sachin Daskhedkar | Director | 26 Oct 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Oct 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Delmax Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 80.61% increase. The company also saw a substantial fall in profitability, with a 24.24% decrease in profit. The company's net worth Soared by an impressive increase of 25.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Delmax Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Delmax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Delmax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delmax Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Delmax Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Delmax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity Bhagyashri Sachin Daskhedkar was appointed as a Director was appointed as a Director on 26 Oct 2020 & has been associated with this company since 5 years 1 month . was completed.
Dattatray Janardhan Pannabhatti was appointed as a Director was appointed as a Director on 17 Jun 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.
The activity Delmax Pharmaceuticals Private Limited was registered on 17 Jun 2019 with Roc Mumbai & aged 6 years 5 months as per MCA records. was completed.
The CIN of Delmax Pharmaceuticals Private Limited is U24100MH2019PTC326834.
Delmax Pharmaceuticals Private Limited is headquartered at Shop No As-05, Udyog, Indrakamal A Type, Gut No. 70, Beed By Pass Road, Aurangabad, Maharashtra, 431001.
Delmax Pharmaceuticals Private Limited was incorporated on 17 June 2019.
The current directors of Delmax Pharmaceuticals Private Limited are
The primary industry of Delmax Pharmaceuticals Private Limited is Manufacturing.
Delmax Pharmaceuticals Private Limited is unlisted.
The authorized capital of Delmax Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Delmax Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX